Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.75 - $2.15 $9,450 - $11,610
-5,400 Reduced 40.91%
7,800 $13,000
Q2 2024

Aug 14, 2024

SELL
$1.97 - $3.53 $26,201 - $46,949
-13,300 Reduced 50.19%
13,200 $28,000
Q1 2024

May 15, 2024

SELL
$2.35 - $3.1 $24,910 - $32,860
-10,600 Reduced 28.57%
26,500 $78,000
Q4 2023

Feb 14, 2024

BUY
$1.9 - $3.28 $42,370 - $73,144
22,300 Added 150.68%
37,100 $104,000
Q3 2023

Nov 14, 2023

BUY
$1.33 - $2.54 $19,684 - $37,592
14,800 New
14,800 $37,000
Q4 2022

Feb 14, 2023

BUY
$2.0 - $2.63 $1,000 - $1,315
500 New
500 $1,000

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $27.7M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.